Market revenue in 2022 | USD 1,189.3 million |
Market revenue in 2030 | USD 2,816.9 million |
Growth rate | 11.4% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polypropylene (PP) |
Historical data covered | 2019 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 21.86% in 2022. Horizon Databook has segmented the North America biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
The increasing per capita healthcare spending in the U.S. in the form of health insurance has been one of the major trends fueling the growth of the biopharma plastics market in North America as it is expected to augment the demand for generic drugs and biopharma plastic-based medical products in the region from 2022 to 2030.
The key biopharma plastic applications in North America are protective wear, containers, disposable connectors, etc. The rising demand for biopharma plastic-based medical products across the region owing to the rapid growth of population and rise in the instances of chronic ailments such as cardiovascular diseases, kidney failure, and liver cirrhosis in North America are further expected to lead biopharmaceutical manufacturers to invest increasingly in biopharma-based research and development activities.
This, in turn, is anticipated to contribute to the demand for biopharma plastics in the region, thereby fueling the growth of the market in North America in the coming years.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biopharma plastics market , including forecasts for subscribers. This continent databook contains high-level insights into North America biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account